ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 16 filers reported holding ENDOLOGIX INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,761,000 | -1.8% | 2,846,000 | -1.0% | 0.08% | -6.2% |
| Q2 2018 | $2,813,000 | +0.7% | 2,874,000 | 0.0% | 0.08% | -14.7% |
| Q1 2018 | $2,793,000 | +0.0% | 2,874,000 | -0.1% | 0.10% | 0.0% |
| Q4 2017 | $2,792,000 | +1.3% | 2,878,000 | 0.0% | 0.10% | -3.1% |
| Q3 2017 | $2,756,000 | +0.5% | 2,878,000 | -0.2% | 0.10% | -4.9% |
| Q2 2017 | $2,741,000 | +137.5% | 2,885,000 | +142.2% | 0.10% | +134.1% |
| Q1 2017 | $1,154,000 | +14.9% | 1,191,000 | +8.8% | 0.04% | +15.8% |
| Q4 2016 | $1,004,000 | +73.7% | 1,095,000 | +83.4% | 0.04% | +81.0% |
| Q3 2016 | $578,000 | -57.2% | 597,000 | -57.8% | 0.02% | -36.4% |
| Q1 2014 | $1,351,000 | -57.2% | 1,415,000 | -55.1% | 0.03% | -59.8% |
| Q4 2013 | $3,158,000 | – | 3,150,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 51,117,000 | $46,140,000 | 1.90% |
| PFM Health Sciences, LP | 6,445,000 | $5,809,000 | 0.16% |
| Partner Investment Management, L.P. | 84,000 | $76,000 | 0.10% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,562,000 | $5,013,000 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,000,000 | $5,423,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,095,000 | $1,004,000 | 0.04% |
| ACUTA CAPITAL PARTNERS, LLC | 96,000 | $86,000 | 0.03% |
| UBS OCONNOR LLC | 1,500,000 | $1,352,000,000 | 0.03% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,305,000 | $6,557,000 | 0.02% |
| Citadel Advisors | 6,230,000 | $5,624,000 | 0.01% |